Literature DB >> 12050289

Serum cortisol and 17-hydroxyprogesterone concentrations in children with classic congenital adrenal hyperplasia.

Robert L Rosenfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12050289     DOI： 10.1210/jcem.87.6.8561

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  Progress in molecular-genetic studies on congenital adrenal hyperplasia due to 11beta-hydroxylase deficiency.

Authors:  Li-Qiang Zhao; Su Han; Hao-Ming Tian
Journal:  World J Pediatr       Date:  2008-05       Impact factor: 2.764

2.  Duration of suppression of adrenal steroids after glucocorticoid administration.

Authors:  John S Fuqua; Deborah Rotenstein; Peter A Lee
Journal:  Int J Pediatr Endocrinol       Date:  2010-03-31

3.  Approach to the adult with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

Authors:  Deborah P Merke
Journal:  J Clin Endocrinol Metab       Date:  2008-03       Impact factor: 5.958

4.  Optimizing the Timing of Highest Hydrocortisone Dose in Children and Adolescents With 21-Hydroxylase Deficiency.

Authors:  Mariska A M Schröder; Antonius E van Herwaarden; Paul N Span; Erica L T van den Akker; Gianni Bocca; Sabine E Hannema; Hetty J van der Kamp; Sandra W K de Kort; Christiaan F Mooij; Dina A Schott; Saartje Straetemans; Vera van Tellingen; Janiëlle A van der Velden; Fred C G J Sweep; Hedi L Claahsen-van der Grinten
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

5.  A pharmacokinetic and pharmacodynamic study of delayed- and extended-release hydrocortisone (Chronocort) vs. conventional hydrocortisone (Cortef) in the treatment of congenital adrenal hyperplasia.

Authors:  Somya Verma; Carol Vanryzin; Ninet Sinaii; Mimi S Kim; Lynnette K Nieman; Shayna Ravindran; Karim A Calis; Wiebke Arlt; Richard J Ross; Deborah P Merke
Journal:  Clin Endocrinol (Oxf)       Date:  2009-05-25       Impact factor: 3.478
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.